Skip to main content
Nanologica logo

Nanologica — Investor Relations & Filings

Ticker · NICA ISIN · SE0005454873 LEI · 54930017L41C7P87LP22 ST Manufacturing
Open in API
Filings indexed 181 across all filing types
Latest filing 2024-09-02 Board/Management Inform…
Country SE Sweden
Listing ST NICA

About Nanologica

https://nanologica.com/

Nanologica is a life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. The company specializes in nanoporous silica particles for preparative chromatography, a critical step in drug production. Its core product, NLAB Saga®, is a spherical, porous silica media engineered for the large-scale purification of peptide drugs, such as insulin and GLP-1 analogues used to treat diabetes and obesity. The product's high mechanical and chemical stability provides effective purification and a long lifetime, which increases productivity and reduces costs for pharmaceutical manufacturers. Nanologica's mission is to lower the manufacturing costs of these drugs, thereby increasing patient access to life-saving treatments. The company is also developing a broader portfolio of purification media.

Recent filings

Filing Released Lang Actions
Förslag till förändring av styrelsen för Nanologica AB (publ)
Board/Management Information Classification · 98% confidence The document explicitly discusses a proposal for a change in the Board of Directors ('Förslag till förändring av styrelsen') to be voted upon at an Extraordinary General Meeting ('extra bolagsstämman'). This directly relates to the composition of the company's leadership and governance structure, specifically concerning board members. While it mentions a general meeting, the core subject is the nomination/appointment of a new director. This aligns best with the 'Board/Management Information' category (MANG), which covers announcements of changes in the board of directors or senior management. It is not a formal proxy statement (PSI) or a declaration of voting results (DVA), but rather the proposal leading up to the vote.
2024-09-02 Swedish
Proposal for Change in the Board of Directors of Nanologica AB (publ)
Board/Management Information Classification · 98% confidence The document explicitly discusses a 'Proposal for Change in the Board of Directors' to be voted upon at an 'Extraordinary General Meeting' (EGM). This directly relates to the composition of the company's leadership and governance structure. The most fitting category is 'Board/Management Information' (MANG), as it announces a proposed change to the board of directors. While it mentions an EGM, the core content is the nomination/proposal itself, not the voting results (DVA) or the general AGM materials (AGM-R).
2024-09-02 English
KALLELSE TILL EXTRA BOLAGSSTÄMMA I NANOLOGICA AB (PUBL)
AGM Information Classification · 98% confidence The document is titled "KALLELSE TILL EXTRA BOLAGSSTÄMMA I NANOLOGICA AB (PUBL)" which translates to "NOTICE OF EXTRAORDINARY GENERAL MEETING IN NANOLOGICA AB (PUBL)". It details the date, location, requirements for participation (registration, proxy), the agenda (including proposals for board changes, approval of prior share issues/guarantees, capital reduction, and authorization for over-allotment), and specific voting majorities required for decisions. This content perfectly matches the definition of materials related to a shareholder meeting, specifically an Extraordinary General Meeting (EGM). Since the definitions provided include 'AGM Information (Code: AGM-R)' for Annual General Meeting materials, and this is an Extraordinary General Meeting, the closest fit among the provided codes that relates to shareholder meetings and voting is either AGM-R or potentially PSI (Proxy Solicitation & Information Statement) or DVA (Declaration of Voting Results). However, a Notice of Meeting itself, detailing the agenda and proposals, is most closely aligned with the general concept of meeting materials. Given the options, AGM-R is the designated code for meeting materials, even though this is an EGM, as there is no specific EGM code. Furthermore, the document is a full notice, not just a proxy statement (PSI) or voting results (DVA). Therefore, AGM-R is the most appropriate classification for a Notice of General Meeting.
2024-08-29 Swedish
NOTICE OF EXTRAORDINARY GENERAL MEETING IN NANOLOGICA AB (PUBL)
AGM Information Classification · 100% confidence The document is explicitly titled "NOTICE OF EXTRAORDINARY GENERAL MEETING IN NANOLOGICA AB (PUBL)". It details the date, time, location, procedures for attendance (including proxy rules and nominee registration), the proposed agenda items (which include electing board members and approving a rights issue), and specific proposals for resolutions related to these items. This content is characteristic of a formal notice convening a shareholder meeting, which aligns directly with the definition of an Annual General Meeting (AGM) notice or related meeting material. Since it is a notice for an Extraordinary General Meeting (EGM) detailing the agenda and proposals, the most appropriate classification is AGM-R (AGM Information), as this category covers presentations and materials shared during general meetings.
2024-08-29 English
NANOLOGICA RESOLVES ON A FULLY UNDERWRITTEN RIGHTS ISSUE OF UNITS OF APPROX. SEK 99.4 MILLION, AN OVER-ALLOTMENT ISSUE OF UP TO SEK 20 MILLION, AND RAISES BRIDGE LOANS OF SEK 15 MILLION
Share Issue/Capital Change Classification · 99% confidence The document is a press release announcing a fully underwritten rights issue of units (shares and warrants) totaling approximately SEK 99.4 million, with an over-allotment option and bridge loans. This clearly details a significant fundraising and capital structure change activity. The key terms are 'Rights Issue,' 'Over-allotment Issue,' 'bridge loans,' and 'subscription commitments.' This aligns directly with the definition of 'Capital/Financing Update' (CAP). Although it mentions a prospectus will be published later, the document itself is the primary announcement of the financing event, not just the announcement of the report (RPA) or a general regulatory filing (RNS).
2024-08-29 English
NANOLOGICA BESLUTAR OM EN FULLT GARANTERAD FÖRETRÄDESEMISSION AV UNITS OM CIRKA 99,4 MSEK, EN ÖVERTILLDELNINGSEMISSION OM UPP TILL CIRKA 20 MSEK, SAMT UPPTAR BRYGGLÅN OM 15 MSEK
Share Issue/Capital Change Classification · 99% confidence The document is a press release announcing a fully underwritten rights issue ('Företrädesemission') and an over-allotment option ('Övertilldelningsemission') to raise approximately 99.4 MSEK initially, plus potential funds from warrants and the over-allotment option. It details the terms of the financing, shareholder commitments, use of proceeds, and the need for an Extraordinary General Meeting (EGM) to approve the rights issue. This content directly relates to fundraising, capital structure changes, and financing activities. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). The document also mentions a separate press release for the EGM notice, but the core subject is the financing itself.
2024-08-29 Swedish

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.